Multiple Antibiotic Allergy Evaluation Strategy (MAAES): A Comparative Effectiveness Study
The Journal of Allergy and Clinical Immunology: In Practice · 2026
DOI: 10.1016/j.jaip.2026.07.005 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Thanaporn Ratchataswan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Inaccurate multiple antibiotic allergy labels to first-line agents (penicillins, cephalosporins, and sulfonamides) restrict optimal therapy and often require sequential evaluations across multiple visits, delaying delabeling and increasing loss to follow-up. OBJECTIVE: To conduct a comparative effectiveness study of the Multiple Antibiotic Allergy Evaluation Strategy (MAAES), comparing its effectiveness, safety, and patient-reported outcomes (PRO) with traditional sequential evaluation (non-MAAES). METHODS: This retrospective cohort study (2014-2024) compared same-day multi-antibiotic testing (MAAES) with non-MAAES in patients with 2 or more low-risk labels. Multivariable regression adjusted for baseline differences and testing era. Inverse probability of treatment weighting (IPTW) and a restricted post-2020 subcohort analysis addressed selection bias and temporal shifts. Outcomes included delabeling efficacy, time to complete delabeling, loss to follow-up, relabeling, adverse events (AEs), and PRO. RESULTS: Baseline differences were present between the MAAES and non-MAAES groups, including penicillin anaphylaxis (1.4% vs 6.6%, P = .002), angioedema (12.4% vs 19.1%, P = .049), maculopapular rash (13.1% vs 24.3%, P = .002), and unknown sulfonamide history (9.5% vs 3.7%, P = .03). MAAES removed 97.4% of labels versus 79.6% for non-MAAES (adjusted odds ratio [aOR]: 9.41, 95% confidence interval [CI]: 5.22-16.95, P < .001). MAAES achieved faster complete delabeling (log-rank χ2 = 42.4, P < .001), with 84.9% versus 21.1% delabeled at the initial visit (restricted mean survival time difference: 2.1 months). Results remained robust in post-2020 and IPTW models. Loss to follow-up (1.3% vs 17.2%; aOR: 0.06, 95% CI: 0.03-0.13, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville,…
Zitieren
APA
Ratchataswan, T., Lee, R., Asiaee, A., Krantz, M. S., Koo, G., Stone, C. A., & Phillips, E. J. (2026). Multiple Antibiotic Allergy Evaluation Strategy (MAAES): A Comparative Effectiveness Study. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.07.005
Vancouver
Ratchataswan T, Lee R, Asiaee A, Krantz MS, Koo G, Stone CA, et al. Multiple Antibiotic Allergy Evaluation Strategy (MAAES): A Comparative Effectiveness Study. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.07.005
BibTeX
@article{Ratchataswan2026,
author = {Ratchataswan, Thanaporn and Lee, Rebecca and Asiaee, Amir and Krantz, Matthew S and Koo, Grace and Stone, Cosby A and Phillips, Elizabeth J},
title = {Multiple Antibiotic Allergy Evaluation Strategy (MAAES): A Comparative Effectiveness Study},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
doi = {10.1016/j.jaip.2026.07.005}
}
EUVIMED